Month: January 2019

“We are getting more and more creative around getting efficiency up and getting our cost of acquisition down,” Amazon’s chief financial officer, Brian Olsavsky, told analysts on the company’s quarterly earnings call on Thursday. AWS beat Microsoft and Google to the market for cloud infrastructure, which companies use to outsource their computing and data storage
0 Comments
Amazon‘s fourth-quarter results beat estimates, but weak guidance and general concerns about slowing growth and heavier investments in 2019 dragged the stock down in after hours trading. Here are the most important numbers: EPS: $6.04 vs. $5.68 estimated, according to Refinitiv Revenue: $72.4 billion vs. $71.9 billion estimated, according to Refinitiv AWS: $7.43 billion vs.
0 Comments
The strikingly dovish tone of the FOMC’s post-meeting statement sent stocks surging higher. But it also generated some conversation around “down-side concerns that the Fed ‘knows more than we do,'” said Catherine L Mann, global chief economist at Citigoup. Mann said, however, that her team’s research indicates that concerns over growth will fade. “Powell argued
0 Comments
Intel named interim CEO Robert Swan to the position permanently Thursday, ending a months-long search following the ouster of Brian Krzanich last June after the company revealed he had a “consensual relationship” with an employee in a violation of company policy. Swan, 58, has been serving as Intel’s interim CEO for seven months and as
0 Comments
Andrew Harrer | Bloomberg | Getty Images Jeff Bezos, founder and chief executive officer of Amazon.com Inc., listens during an Economic Club of Washington discussion in Washington, D.C., U.S., on Thursday, Sept. 13, 2018.  The last two times Amazon has reported quarterly results, revenue fell short of expectations. Now, investors are facing the prospects of
0 Comments
Kristoffer Tripplaar | AP Celgene Corporation in San Diego, California Celgene, which is being bought by Bristol-Myers Squibb, reported a better-than-expected fourth-quarter profit on Thursday, driven mainly by higher sales of psoriasis drug Otezla. Bristol-Myers agreed to buy Celgene for about $74 billion earlier this month, a deal that will expand its pipeline of cancer
0 Comments
Check out the companies making headlines before the bell: DowDupont – The chemical maker earned an adjusted 88 cents per share for the fourth quarter, a penny a share above estimates. Revenue was short of estimates, however, on lower demand for automotive and appliance-related products. General Electric – GE missed estimates by 5 centss a
0 Comments
Marlboro-maker Altria on Thursday reported fourth-quarter financial results that matched analyst expectations and gave investors more insight on its new e-cigarette and marijuana investments as its core cigarette business shrinks. Altria in Decemberinvested $1.8 billion for a 45 percent stake in Canadian cannabis company Cronos and $12.8 billion for a 35 percent stake in e-cigarette
0 Comments
General Electric shares surged Thursday after the conglomerate posted better-than-expected revenue, as strong aviation results in the fourth quarter overshadowed lingering problems in the GE Capital and power businesses. CEO Larry Culp said that industrial revenue would be up “low-to-mid single digits” in 2019. He added the company’s power business sees a “flat to slightly
0 Comments
The strategic push comes amidst a broad shake-up in the private jet market. New apps have made it easier to book flights on-demand, while a glut of planes and competitors are all vying for a dominant share. VistaJet last year acquired XOJET, the on-demand charter company, while Directional Aviation bought U.K.-based PrivateFly, a digital booking
0 Comments
After a barrage of mostly negative headlines in recent months, Facebook reports after the bell Wednesday. Despite the headwinds, analysts remain mostly bullish that the social media titan looks strong heading into the report where they’ll be watching for key metrics on ad revenue, privacy and messenger integration. Facebook has come under tremendous pressure from
0 Comments